Monitor the special meeting outcome on December 9, 2026 for shareholder approval of the reverse split authorization. The wide ratio range (up to 1-for-250) suggests management wants maximum flexibility to address potential Nasdaq minimum bid price compliance.
Price Chart
Executive Summary
20/20 Biolabs, Inc. filed definitive additional proxy soliciting materials (DEFA14A) for a special meeting of stockholders on December 9, 2026, seeking authorization for a reverse stock split at a ratio between 1-for-2 and 1-for-250, effective any time before December 31, 2028. The board recommends voting FOR the proposal. This is a routine capital structure management filing to maintain exchange listing compliance.
Key Financial Metrics
Key Facts
- Special meeting scheduled for December 9, 2026 at 10:00 AM Eastern Time
- Proposal to authorize board to implement reverse stock split at ratio of not less than 1-for-2 and not more than 1-for-250
- Reverse split authorization valid until December 31, 2028
- Record date for stockholders is October 20, 2026
- Board recommends voting FOR all proposals
- Second proposal to adjourn meeting if needed to solicit additional proxies
Financial Impact
No financial figures disclosed in filing
Risk Factors
- Shareholder may not approve the reverse split authorization
- If approved, actual split ratio and timing remain at board discretion, creating uncertainty
- Reverse splits often carry negative signaling for micro-cap stocks
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-111349 |
| Document: 0001213900-26-111349-index-headers.html | 0001213900-26-111349 |
| Document: 0001213900-26-111349-index.html | 0001213900-26-111349 |
| Document: 0001213900-26-111349.txt | 0001213900-26-111349 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | DEFA14A | $0.2507 | awaiting T+5 | — | $0.2325 (−7.26%) |
Oct 21, 2026 5d ago | DEF 14A | $0.2507 | awaiting T+5 | — | $0.2325 (−7.26%) |
Aug 17, 2026 10w ago | 8-K | $0.5200 $0.5282 | ▲ +1.58% | ▲ +1.78% | $0.2325 (−55.29%) |
Aug 17, 2026 10w ago | Press Release | $0.5503 $0.5182 | ▼ −5.83% | ▼ −4.64% | $0.2325 (−57.75%) |
Aug 5, 2026 11w ago | 8-K | $0.4413 $0.4610 | ▲ +4.46% | ▲ +4.11% | $0.2325 (−47.31%) |
Jul 1, 2026 16w ago | 8-K | $0.6095 $0.5851 | ▼ −4.00% | ▼ −4.26% | $0.2325 (−61.85%) |
Jun 23, 2026 17w ago | DEFA14A | $0.5669 $0.6095 | ▼ −7.51% | ▼ −5.81% | $0.2325 (+58.99%) |
May 26, 2026 21w ago | 8-K | $0.9700 $0.8400 | ▼ −13.40% | ▼ −13.87% | $0.2325 (−76.03%) |
May 20, 2026 22w ago | 8-K | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2325 (+80.79%) |
May 20, 2026 22w ago | Press Release | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2325 (+80.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers